Alvotech
Market Cap
$1.19B
P/E Ratio
15.92
EPS
$0.24
Dividend Yield
0.00%
52-Week Range
$3.45 — $11.85
Volume
389.88K
Avg Volume
507.34K
Beta
0.18
P/E (TTM)
15.92
Forward P/E
12.48
PEG Ratio
2.01
P/S (TTM)
2.12
P/B (TTM)
-6.59
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.26%
ROA (TTM)
0.05%
ROIC
—
Gross Margin
0.55%
Operating Margin
0.08%
Net Margin
—
Debt/Equity
-7.25
Current Ratio
1.42
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.30%
EPS Growth (5Y)
-0.80%
Sales Growth (3Y)
+1.90%
Sales Growth (5Y)
+1.27%
EPS Est (This Year)
$0.31
EPS Est (Next Year)
$0.58
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.14
Price Target Range
Consensus Target: $8.60(125.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
311.60M
Float
106.07M
Free Float %
34.04%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
IS
Exchange
NASDAQ
IPO Date
2022-06-16
Employees
1012
CEO
Vilhelm Robert Wessman
Index Membership
—
Website
https://www.alvotech.com
Alvotech (ALVO) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $1.19B, a P/E ratio of 15.92, ALVO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ALVO against other stocks using dozens of fundamental and technical filters.
Alvotech (ALVO) has a trailing twelve-month (TTM) P/E ratio of 15.92. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Alvotech (ALVO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Alvotech (ALVO) has a market capitalization of $1.19 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.